Venture Map · Round
Inbiomotion — Other
Announced 2021-01-21 · Barcelona · Diagnostics / Oncology
Inbiomotion, an IRB Barcelona spin-off behind the MAF biomarker test for early breast cancer, closed an oversubscribed round of undisclosed size led by Alta Life Sciences, with existing investor ICF.
RoundOther
LeadAlta Life Sciences
Date2021-01-21
CityBarcelona
SectorDiagnostics / Oncology
